Curated GI articles September 30th, 2022: 5 leaders on the future of GI | Microbiome co raises $1.85M | 5 numbers to keep a watch with projected GI salary shortage
Curated GI articles September 30th, 2022:
5 leaders on the future of GI | Microbiome co raises $1.85M | 5 numbers to keep a watch with projected GI salary shortage
How Private Equity Helps Gastroenterology + Physical Therapy Practices (Fifth Third Bank)
For practices that do become PE partners, there may be numerous benefits, though transactions are structured not to interfere in the clinical arena.
The future of gastroenterology: 5 leaders’ insights (Becker’s GI & Endoscopy)
From new technologies to physician autonomy, here are five leaders’ perspectives on where the GI industry is headed.
Good for the gut (health): Gusto Global raises $1.85M (WRAL TechWire)
Gusto Global, which focuses on the microbiome and has developed a breakthrough therapy for treating Crohn’s disease, has raised nearly $2 million in new funding.
GI psychology a ‘rewarding partnership’ for both patients, providers (Healio)
The piece highlights the benefits of providing brain-gut psychotherapies as integrated care for patients with chronic digestive conditions and discusses the progress and challenges we face in implementing this approach.
Clinical Practice Update: How to manage short bowel syndrome (SBS) (AGA)
Experts call for maintaining compensatory hyperphagia rather than excessive dietary restrictions for patients with SBS.
Why Private Practice Will Always Survive: 7 Doctors Who Left Employment Tell Why (Medscape)
Seven physicians talked to Medscape about why they chose private practice.
5 numbers GI leaders should watch (Becker’s GI & Endoscopy)
From a projected gastroenterologist shortage to a salary reduction, here are five numbers gastroenterology leaders should keep an eye on.
Top 20 hospitals by gastroenterology procedure volume (Definitive Healthcare)
The article highlights a list of 20 hospitals ranked by volume of outpatient gastroenterology procedures as compiled by Definitive Healthcare.
FDA clears Medtronic’s powder-to-gel bloodstopping spray for upper GI bleeds (Fierce Biotech)
The Nexpowder system includes a hand-held spray controller that connects to a catheter. Once the bright blue powder is sprayed onto a bleeding site, it reacts with the blood to form a gel.
Could Your Patients Benefit? New Trials in Noncolorectal GI Cancer (Medscape)
Several new studies in noncolorectal GI cancers have launched in recent months. Find out if one of your patients benefit from participating.
Capsule delivery of Fecal Microbiota Transplant has similar effectiveness to transplant by colonoscopy (EurekAlert)
While highly effective overall, the research team says patient selection is a key factor to optimizing FMT success.
RUSH to Partner With Medtronic to Create Innovation Hub (Newswise)
The hub is designed to bring together the brightest minds from industry and academic medicine to lead research and develop technology and treatments for patients with complex digestive diseases.
CorEvitas® IBD Registry Launches Precision Medicine Program to Expand Treatment Insights & Advance Care (PR Newswire)
This pivotal initiative will pave the way for the next wave of IBD therapeutics and diagnostics.
69% of physicians want a single-payer system (Becker’s ASC Review)
Sixty-nine percent of physicians would like some form of a single-payer system, according to Medscape’s 2022 “Physicians Rate Healthcare Access Report.”
A Look at the Treatment Landscape for Gastroparesis (ReachMD)
Dr. Peter Buch is joined by Dr. Mandu Grover, an Associate Professor of Medicine at the Mayo Clinic, to take a look at current treatment options.
Hidden Contributors to IBD (GI & Endoscopy News)
The article focuses on hidden contributors to Crohn’s disease or ulcerative colitis, with studies highlighting factors such as allergens and a biomarker that may allow the prediction of severe Crohn’s disease years before it develops.
Orally ingestible robotic drug delivery device overcomes barriers of the gastrointestinal environment (News-Medical)
RoboCap, an orally ingestible robotic drug delivery device that overcomes many of the challenges of the gastrointestinal environment to deliver its payload.
Biomerica’s EZ Detect™ Colon Disease and Aware® Breast Self Exam Test Now Available on Amazon (Globe Newswire)
EZ Detect™ is a simple 2-minute, at-home test which detects an early warning sign of colorectal cancer.
More Hot headlines in GI
2023 Gastroenterology Reimbursement and Coding Update Course (ASGE)
Study: Physician-led hospitals earn nearly 7 times higher patient experience rating (Fierce Healthcare)
Combination extends OS in metastatic colorectal cancer (Healio)
Fujifilm receives regulatory approval for its latest generation Endoscopic Ultrasound endoscope (PR Newswire)
Pandemic-related CRC screening delays affect older adults most (MDedge)
Anticipate More Adenomas After FIT-Positive Colonoscopies (Medpage Today)
Electrical stimulation alleviates abdominal pain, symptoms in IBS with constipation (Healio)
Motus GI Named a Sole Source Supplier with U.S. Department of Veteran Affairs (Globe Newswire)
Utah doctors use new AI technology to fight cancer (KUTV)
Videos: Interviews with GI Leaders (NextServices)
COVID-19: The Way Forward for Gastroenterology Practices